A peptide derived from acetylcholinesterase induces neuronal cell death: characterisation of possible mechanisms
- 120 Downloads
Acetylcholinesterase (AChE) exhibits functions unrelated to the catalysis of acetylcholine (ACh) in particular during development. Although the underlying mechanism(s) is presently unknown, a candidate peptide fragment (AChE-peptide) has recently been identified, and been shown to induce a continuum of apoptotic and necrotic neuronal cell death in rat hippocampal organotypic cultures. The aim of this study was to trace the cell death pathway initiated by AChE-peptide. Using specific antagonists, it was possible to track a series of cellular events following application of 1 nM AChE-peptide: NMDA receptor activation, opening of the L-type voltage gated calcium channel, activation of calcium/calmodulin kinase II, generation of reactive oxygen species and caspase activation. Pharmacological interception at any stage of this cascade blocked the effect of 1 nM AChE-peptide on neurite retraction. Lactate dehydrogenase (LDH) release, a marker for cell lysis, was unaffected by 1 nM AChE-peptide. In contrast, cell death induced by 1 mM AChE-peptide, monitored as neurite retraction and increased LDH efflux, was not offset by any drug treatment. These data suggest that nanomolar concentrations of AChE-peptide exhibit pathophysiological activity via an apoptotic pathway that could play an important role in neuronal development and neurodegeneration.
KeywordsAcetylcholinesterase Cell death Hippocampus AChE-peptide
We thank Synaptica Ltd. (Oxford, UK) for support, Dr Steven Butcher for helpful comments, and Kevin Pryor for technical assistance.
- Day T, Greenfield SA (2003) Bioactivity of a peptide derived from acetylcholinesterase in hippocampal organotypic cultures. Exp Brain Res (in press)Google Scholar
- Ferri KF, Kroemer G (2001) Organelle-specific initiation of cell death pathways. Nat Cell Biol 3:E255–E263Google Scholar
- Grundman M (2000) Vitamin E and Alzheimer’s disease: the basis for additional clinical trials. Am. J Clin Nutr 71 [Suppl]:630s–636sGoogle Scholar
- Guo Q, Sebastain L, Sopher BL, Miller MW, Ware CB, Martin GM, Mattson MP (1999) Increased vulnerability of hippocampal neurons from presenilin-1 mutant knock-in mice to amyloid β-peptide toxicity: Central roles of superoxide production and caspase activation. J Neurochem 72:1019–1029CrossRefPubMedGoogle Scholar
- Han BH, Xu D, Choi J, Han Y, Xanthoudakis S, Roy S, Tam J, Vaillancourt J, Colucci J, Siman R, Giroux A, Robertson GS, Zamboni R, Nicholson DW, Holtzman DM (2002) Selective, reversible caspase-3 inhibitor is neuroprotective and reveals distinct pathways of cell death after neonatal hypoxic-ischemic brain injury. J Biol Chem 277:30128–30136CrossRefPubMedGoogle Scholar
- Holmes C, Jones SA, Budd TC, Greenfield SA (1996) A non-cholinergic, trophic action of recombinant acetylcholinesterase on mid-brain dopaminergic neruons. J Neurosci Res 49:1–12Google Scholar
- Nagy ZS, Esiri MM, Smith AD (1998) The cell division cycle and the pathophysiology of Alzheimer’s disease. Neuroscience 87:731–739Google Scholar